U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Metastatic prostate carcinoma

MedGen UID:
215232
•Concept ID:
C0936223
•
Neoplastic Process
Synonyms: Metastatic Prostate Cancer; metastatic prostate cancer; Metastatic Prostate Carcinoma; metastatic prostate carcinoma; Prostate Cancer Metastatic; prostate cancer metastatic; Prostate Carcinoma Metastatic; prostate carcinoma metastatic
 
Monarch Initiative: MONDO:0004956

Definition

A carcinoma that arises from the prostate gland and has spread to other anatomic sites. [from NCI]

Professional guidelines

PubMed

Treatment options in hormone-refractory metastatic prostate carcinoma.
Fusi A, Procopio G, Della Torre S, Ricotta R, Bianchini G, Salvioni R, Ferrari L, Martinetti A, Savelli G, Villa S, Bajetta E
Tumori 2004 Nov-Dec;90(6):535-46. doi: 10.1177/030089160409000601. PMID: 15762353
Bisphosphonates in the management of prostate carcinoma metastatic to the skeleton.
Papapoulos SE, Hamdy NA, van der Pluijm G
Cancer 2000 Jun 15;88(12 Suppl):3047-53. doi: 10.1002/1097-0142(20000615)88:12+<3047::aid-cncr22>3.3.co;2-l. PMID: 10898350
Prospects of immunotherapy for the treatment of prostate carcinoma--a review.
Hillman GG, Triest JA, Cher ML, Kocheril SV, Talati BR
Cancer Detect Prev 1999;23(4):333-42. doi: 10.1046/j.1525-1500.1999.99027.x. PMID: 10403905

Recent clinical studies

Etiology

Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.
Sureka SK, Misra A, Raj H, Shukla A, Singh UP
Int Urol Nephrol 2023 May;55(5):1133-1137. Epub 2023 Mar 14 doi: 10.1007/s11255-023-03531-2. PMID: 36917412
Concomitant intraductal carcinoma of the prostate and response to hormonal therapy in metastatic prostate carcinoma.
Abascal-Junquera JM, Fumadó-Ciutat L, Gasa-Galmes B, Costa-Planells M, Munarriz-Polo M, Sanromà-Salvà A, Polaina-Barroso L, Solà-Marqués C, Juanpere-Rodero N, Lloreta-Trull J, Cecchini-Rosell L
Actas Urol Esp (Engl Ed) 2021 Jul-Aug;45(6):455-460. Epub 2021 Jun 16 doi: 10.1016/j.acuroe.2020.06.004. PMID: 34147428
Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving (225)Ac-PSMA-617 Radioligand Therapy.
Sathekge M, Bruchertseifer F, Vorster M, Lawal IO, Knoesen O, Mahapane J, Davis C, Reyneke F, Maes A, Kratochwil C, Lengana T, Giesel FL, Van de Wiele C, Morgenstern A
J Nucl Med 2020 Jan;61(1):62-69. Epub 2019 May 17 doi: 10.2967/jnumed.119.229229. PMID: 31101746
Expression of Bcl-2 and Bax in advanced or metastatic prostate carcinoma.
Anvari K, Seilanian Toussi M, Kalantari M, Naseri S, Karimi Shahri M, Ahmadnia H, Katebi M, Sedighi Pashaki A, Dayani M, Broumand M
Urol J 2012 Winter;9(1):381-8. PMID: 22395836
A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma.
Serpa Neto A, Tobias-Machado M, Esteves MA, Senra MD, Wroclawski ML, Fonseca FL, dos Reis RB, Pompeo AC, Del Giglio A
BMC Urol 2010 May 19;10:9. doi: 10.1186/1471-2490-10-9. PMID: 20482867Free PMC Article

Diagnosis

Concomitant intraductal carcinoma of the prostate and response to hormonal therapy in metastatic prostate carcinoma.
Abascal-Junquera JM, Fumadó-Ciutat L, Gasa-Galmes B, Costa-Planells M, Munarriz-Polo M, Sanromà-Salvà A, Polaina-Barroso L, Solà-Marqués C, Juanpere-Rodero N, Lloreta-Trull J, Cecchini-Rosell L
Actas Urol Esp (Engl Ed) 2021 Jul-Aug;45(6):455-460. Epub 2021 Jun 16 doi: 10.1016/j.acuroe.2020.06.004. PMID: 34147428
Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era.
Tucci M, Caffo O, Buttigliero C, Cavaliere C, D'aniello C, Di Maio M, Kinspergher S, Maines F, Rizzo M, Rossetti S, Veccia A, Scagliotti GV, Facchini G
Cancer Treat Rev 2019 Mar;74:35-42. Epub 2019 Jan 7 doi: 10.1016/j.ctrv.2019.01.002. PMID: 30738364
Metastatic Prostate Carcinoma from Imperial Rome (1st to 2nd Centuries AD).
Minozzi S, Lunardini A, Caldarini C, Caramella D, Fornaciari G, Catalano P, Giuffra V
Pathobiology 2018;85(5-6):289-299. Epub 2018 Sep 17 doi: 10.1159/000490798. PMID: 30223259
Treatment options in hormone-refractory metastatic prostate carcinoma.
Fusi A, Procopio G, Della Torre S, Ricotta R, Bianchini G, Salvioni R, Ferrari L, Martinetti A, Savelli G, Villa S, Bajetta E
Tumori 2004 Nov-Dec;90(6):535-46. doi: 10.1177/030089160409000601. PMID: 15762353
Prostate-specific antigen and early detection of prostate cancer.
Chu TM
Tumour Biol 1997;18(2):123-34. doi: 10.1159/000218023. PMID: 9222310

Therapy

Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era.
Tucci M, Caffo O, Buttigliero C, Cavaliere C, D'aniello C, Di Maio M, Kinspergher S, Maines F, Rizzo M, Rossetti S, Veccia A, Scagliotti GV, Facchini G
Cancer Treat Rev 2019 Mar;74:35-42. Epub 2019 Jan 7 doi: 10.1016/j.ctrv.2019.01.002. PMID: 30738364
A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma.
Serpa Neto A, Tobias-Machado M, Esteves MA, Senra MD, Wroclawski ML, Fonseca FL, dos Reis RB, Pompeo AC, Del Giglio A
BMC Urol 2010 May 19;10:9. doi: 10.1186/1471-2490-10-9. PMID: 20482867Free PMC Article
Bicalutamide-associated fulminant hepatotoxicity.
O'Bryant CL, Flaig TW, Utz KJ
Pharmacotherapy 2008 Aug;28(8):1071-5. doi: 10.1592/phco.28.8.1071. PMID: 18657023
Treatment options in hormone-refractory metastatic prostate carcinoma.
Fusi A, Procopio G, Della Torre S, Ricotta R, Bianchini G, Salvioni R, Ferrari L, Martinetti A, Savelli G, Villa S, Bajetta E
Tumori 2004 Nov-Dec;90(6):535-46. doi: 10.1177/030089160409000601. PMID: 15762353
Prostate-specific antigen and early detection of prostate cancer.
Chu TM
Tumour Biol 1997;18(2):123-34. doi: 10.1159/000218023. PMID: 9222310

Prognosis

Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving (225)Ac-PSMA-617 Radioligand Therapy.
Sathekge M, Bruchertseifer F, Vorster M, Lawal IO, Knoesen O, Mahapane J, Davis C, Reyneke F, Maes A, Kratochwil C, Lengana T, Giesel FL, Van de Wiele C, Morgenstern A
J Nucl Med 2020 Jan;61(1):62-69. Epub 2019 May 17 doi: 10.2967/jnumed.119.229229. PMID: 31101746
Iris metastasis from prostate carcinoma: a case report and review of the literature.
Martin V, Cuenca X, Lopez S, Albertini AF, Lang P, Simon JM, Hémery CG, Feuvret L, Mazeron JJ
Cancer Radiother 2015 Aug;19(5):331-3. Epub 2015 Apr 6 doi: 10.1016/j.canrad.2014.12.008. PMID: 25858707
Expression of Bcl-2 and Bax in advanced or metastatic prostate carcinoma.
Anvari K, Seilanian Toussi M, Kalantari M, Naseri S, Karimi Shahri M, Ahmadnia H, Katebi M, Sedighi Pashaki A, Dayani M, Broumand M
Urol J 2012 Winter;9(1):381-8. PMID: 22395836
A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma.
Serpa Neto A, Tobias-Machado M, Esteves MA, Senra MD, Wroclawski ML, Fonseca FL, dos Reis RB, Pompeo AC, Del Giglio A
BMC Urol 2010 May 19;10:9. doi: 10.1186/1471-2490-10-9. PMID: 20482867Free PMC Article
Bicalutamide-associated fulminant hepatotoxicity.
O'Bryant CL, Flaig TW, Utz KJ
Pharmacotherapy 2008 Aug;28(8):1071-5. doi: 10.1592/phco.28.8.1071. PMID: 18657023

Clinical prediction guides

Is systematic prostate biopsy an overkill in metastatic prostate carcinoma ? A prospective validation.
Sureka SK, Misra A, Raj H, Shukla A, Singh UP
Int Urol Nephrol 2023 May;55(5):1133-1137. Epub 2023 Mar 14 doi: 10.1007/s11255-023-03531-2. PMID: 36917412
Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving (225)Ac-PSMA-617 Radioligand Therapy.
Sathekge M, Bruchertseifer F, Vorster M, Lawal IO, Knoesen O, Mahapane J, Davis C, Reyneke F, Maes A, Kratochwil C, Lengana T, Giesel FL, Van de Wiele C, Morgenstern A
J Nucl Med 2020 Jan;61(1):62-69. Epub 2019 May 17 doi: 10.2967/jnumed.119.229229. PMID: 31101746
Expression of Bcl-2 and Bax in advanced or metastatic prostate carcinoma.
Anvari K, Seilanian Toussi M, Kalantari M, Naseri S, Karimi Shahri M, Ahmadnia H, Katebi M, Sedighi Pashaki A, Dayani M, Broumand M
Urol J 2012 Winter;9(1):381-8. PMID: 22395836
A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma.
Serpa Neto A, Tobias-Machado M, Esteves MA, Senra MD, Wroclawski ML, Fonseca FL, dos Reis RB, Pompeo AC, Del Giglio A
BMC Urol 2010 May 19;10:9. doi: 10.1186/1471-2490-10-9. PMID: 20482867Free PMC Article
Bicalutamide-associated fulminant hepatotoxicity.
O'Bryant CL, Flaig TW, Utz KJ
Pharmacotherapy 2008 Aug;28(8):1071-5. doi: 10.1592/phco.28.8.1071. PMID: 18657023

Recent systematic reviews

A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma.
Serpa Neto A, Tobias-Machado M, Esteves MA, Senra MD, Wroclawski ML, Fonseca FL, dos Reis RB, Pompeo AC, Del Giglio A
BMC Urol 2010 May 19;10:9. doi: 10.1186/1471-2490-10-9. PMID: 20482867Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...